Decreased CD27 on B lymphocytes in patients with primary hepatocellular carcinoma

J Int Med Res. 2012;40(1):307-16. doi: 10.1177/147323001204000131.

Abstract

Objectives: Hepatitis B virus (HBV) replicates in the liver and can lead to hepatocellular carcinoma (HCC). The B lymphocytes may provide a means for HBV to persist although the mechanism remains unknown. This study aimed to characterize B lymphocyte subset phenotypes and measure levels of B lymphocyte-related cytokines in HCC patients.

Methods: The study population included 38 HCC patients and 30 healthy control subjects. Phenotyping of B lymphocytes was performed by flow cytometry. Serum cytokine levels were measured using a cytometric bead array immunoassay.

Results: The ratio of naïve (CD29+CD27-) to memory (CD19+CD27+) B lymphocytes was significantly higher in HCC patients compared with healthy controls. The percentage of memory B lymphocytes decreased with the progression of HCC. Levels of interleukin (IL)-6 and IL-10 were significantly increased in HCC patients compared with healthy controls.

Conclusions: The depletion of memory B lymphocytes may contribute to unresponsiveness to HBV or to HCC. This humoral defect might be related to raised production of IL-6 and IL-10.

MeSH terms

  • Adult
  • Aged
  • Antigens, CD19
  • B-Lymphocytes / metabolism*
  • Carcinoma, Hepatocellular / blood
  • Carcinoma, Hepatocellular / immunology*
  • Case-Control Studies
  • Cytokines / blood
  • Demography
  • Female
  • Flow Cytometry
  • Humans
  • Immunologic Memory / immunology
  • Liver Neoplasms / blood
  • Liver Neoplasms / immunology*
  • Male
  • Middle Aged
  • Tumor Necrosis Factor Receptor Superfamily, Member 7 / metabolism*

Substances

  • Antigens, CD19
  • Cytokines
  • Tumor Necrosis Factor Receptor Superfamily, Member 7